Nathalia Cristine Lima Azevedo

Nathalia Cristine Lima Azevedo

Auto-generated profile, based on publicly available information

Nathalia Cristine Lima Azevedo

Brazilian Nanotechnology National Laboratory (LNNano), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas 13083-100, Sao Paulo, Brazil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2023 in Journal of Materials Chemistry C
Verified
Journal Article
Closed access
PDF file
ALAlessandro Henrique de Lima
Alessandro Henrique de Lima
ISIsabella Scarpa
Isabella Scarpa
NANathalia Cristine Lima Azevedo
Nathalia Cristine Lima Azevedo
GLGabrielle Coelho Lelis
Gabrielle Coelho Lelis
MSMathias Strauss
Mathias Strauss
Rafael Furlan De OliveiraRafael Furlan De Oliveira
Rafael Furlan De Oliveira
Graphene oxide (GO) is at the center of a multitude of applications in different fields of nanotechnology. The increasing use of GO has led to its massive commercialization, which requires rigorous quality control that assures its properties and safety. However, both GO properties and safety are very dependent on the presence, quantity, and type of impurities, and one type of particular impurity frequently neglected in GO research is oxidative debris (ODs). ODs are highly oxidized nanometric carbonaceous fragments produced during GO processing. They adhere to the GO flake surfaces via non-covalent interactions and are present even in samples purified by standard methods. ODs have been extensively reported to impact the properties of carbon nanotubes, but their effects remain relatively overlooked for GO. Here, a decade of scientific research on ODs in GO is reviewed, covering aspects that include the emergence of ODs in the GO synthesis, the protocols for their removal and isolation, the ODs’ structural and chemical composition, and more importantly their influence on several GO properties, such as electrical, electrochemical, adsorptive, biological, toxicological, among others. This review aims to stimulate the debate and further investigations on such an intriguing topic, ultimately contributing to a deeper understanding and application of GO.

1 January 2024 in Journal of the Brazilian Chemical Society
Verified
Journal Article
Closed access
NANathalia Azevedo
Nathalia Azevedo
AMAline Maria Zigiotto de Medeiros
Aline Maria Zigiotto de Medeiros
GSGabriela Helena Da Silva
Gabriela Helena Da Silva
MBMilena Brito
Milena Brito
JFJoão Faria
João Faria
DMDiego Stéfani T. Martinez
Diego Stéfani T. Martinez
The graphene oxide (GO)-silver nanoparticles (AgNPs) hybrid material (GO-AgNPs) has garnered significant interest due to its ability to combine the unique properties of GO and AgNPs, showing promise applications in biomedicine, nanocomposites, biosensors, and antimicrobial materials. However, further investigation is needed to understand the nanobio-interactions and toxicity of GO-AgNPs nanohybrid. Assessing the toxicity of GO-AgNPs on red blood cells (hemolysis) and its interactions with blood biomolecules (biocorona formation) is mandatory for biomedical applications and safety evaluation of this material. In this work, we investigate the biocorona formation associated with GO-AgNPs after interaction with human plasma and hemolysate biomolecules linked to its hemolytic effects. Both GO and GO-AgNPs exhibited a dose-dependent hemolytic effect, with GO-AgNPs showing three times greater hemolysis than GO. Nonetheless, biocorona formation fully mitigated the hemolytic effect of both materials, however, morphological damages in red blood cells may occur yet. Our findings show that biocorona formation dramatically changes the surface chemistry, colloidal behavior and toxicity of this hybrid material. Finally, this work contributes to understanding how graphene-silver nanoparticles interact with blood components to design strategies to minimize toxicity risks and enhance their applications in biomedicine and nanobiotechnology.